Delivery Order SPE2DR25D3103-SPE2DR26F9P21
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $104,511.07 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units). This firm fixed-price contract, which was not set-aside and competitively awarded, was executed on August 5, 2025, with an ultimate completion date of August 6, 2025. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency has awarded a delivery order valued at $10,816.44 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units). This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by July 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $53,875.93 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count supply). This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by November 14, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same city. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,869.18 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (30-count supply) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price, competitively awarded contract involves no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $58,668.40 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units) on September 25, 2025, with an ultimate completion date of September 26, 2025. This competitively awarded, firm fixed-price contract was issued without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $34,302.95 delivery order to AmerisourceBergen Drug Corp for 90-count supplies of Gemtesa 75 mg tablets, with a completion deadline of December 3, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor's Corporate Office division located in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,513.59 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Gemtesa 75 mg tablets (90 count). The award represents a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-competitive set-aside award was made through the Defense Logistics Agency's medical supply procurement...
- The Defense Logistics Agency awarded a delivery order valued at $92,969.92 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count units) on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count units) with a ceiling value of $116,408.08. The order, issued on December 11, 2025, with an ultimate completion date of December 12, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $16,747.27 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office located in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9P21Delivery Order
The Defense Logistics Agency has awarded a $39,210.32 delivery order to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-unit quantity). This non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of December 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle that runs through December 2026. AmerisourceBergen serves as a primary pharmaceutical distributor for federal medical procurement, supplying the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. As a major healthcare solutions provider, the company competes successfully for federal contracts through open competition and maintains extensive experience fulfilling diverse pharmaceutical supply requirements across multiple therapeutic domains. This award for Gemtesa, a medication used in urology, exemplifies the company's role in supporting military and veteran healthcare systems through competitively awarded delivery orders under its comprehensive DLA contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $39.2k | 12/11/25 |